Nivalis Therapeutics, Inc. (NVLS)
(Delayed Data from NSDQ)
$2.40 USD
+0.05 (2.13%)
Updated Jul 24, 2017 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[NVLS]
Reports for Purchase
Showing records 1 - 16 ( 16 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Spotlight on NACFC 2016: Hot Topics and Abstracts of InterestThis report contains brief updates on the following: NVLS, PRQR, PTI, VRTX. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Update on the Timetable and Significance of the Expanded Phase 2 Program
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Industry: Medical - Drugs
Spotlight on NACFC 2015: Hot Topics and Abstracts of Interest
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
A Molecule for All Seasons; Initiating with a Buy and $30 PT
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: FEIN A
Industry: Semiconductor Equipment - Wafer Fabrication
SEMICON - Day 1: NVLS Upbeat 2Q But Slowing Orders; 2Q up 20%, 3Q up 0-10%
Provider: Merriman Curhan Ford & Co.
Analyst: ONG B
Industry: Electronics - Manufacturing Machinery
|